STOCK TITAN

Getty Images (GETY) Rule 144 Notice: Insider Plans to Sell 7,220 Shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Form 144 notice for Getty Images Holdings, Inc. (GETY) shows an intended sale of 7,220 common shares through Morgan Stanley Smith Barney on the NYSE with an aggregate market value of $14,512.20 and approximately 414,811,306 shares outstanding. The 7,220 shares were acquired on 09/20/2025 as restricted stock that vested under a registered plan and the planned sale date is 09/23/2025. The filing also discloses multiple insider sales during the past three months by Mikael Cho and Stephanie Lauren Liveranii, including transactions on 09/15/2025, 09/12/2025, and 06/25/2025. The filer certifies no undisclosed material adverse information.

Positive

  • Planned sale fully disclosed: 7,220 common shares and broker details (Morgan Stanley) are provided.
  • Acquisition transparency: Shares were acquired via restricted stock vesting on 09/20/2025 and payment details are noted.
  • Recent insider transactions listed: Multiple sales by Mikael Cho and Stephanie Lauren Liveranii are disclosed for the past three months, improving transparency.

Negative

  • Insider selling activity: Several sizable sales occurred in the past three months (examples include 26,913 and 15,842 shares on 09/12/2025 and 09/15/2025), which may concern investors monitoring insider liquidity.

Insights

TL;DR Routine insider sale notice: 7,220 vested shares to be sold; several recent insider sales disclosed.

The filing is a standard Rule 144 notice reporting a planned disposition of 7,220 common shares acquired by restricted stock vesting on 09/20/2025, to be executed through Morgan Stanley on 09/23/2025. The aggregate market value reported is $14,512.20 against total outstanding shares of 414,811,306, indicating the trade size is immaterial relative to share base. Multiple prior sales by two insiders are listed, providing transparency about recent insider liquidity events but not indicating altered corporate fundamentals.

TL;DR Compliance-focused filing: restricted shares vested and planned sale disclosed; certifications included.

The document fulfills Rule 144 disclosure requirements by identifying the nature of acquisition (restricted stock vesting), the broker, and planned sale date, and by listing recent insider sales by named individuals. The signer affirms no undisclosed material adverse information and references Rule 10b5-1 trading-plan language, which is standard. From a governance perspective, the filing demonstrates procedural compliance and insider transparency without revealing a change in leadership or control.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What shares does the GETY Form 144 propose to sell?

The notice proposes sale of 7,220 common shares through Morgan Stanley with an aggregate market value of $14,512.20.

When were the shares acquired that are proposed for sale in the GETY filing?

The shares were acquired on 09/20/2025 as restricted stock that vested under a registered plan.

What is the planned sale date and exchange for the GETY securities?

The approximate sale date is 09/23/2025 and the securities are to be sold on the NYSE.

Who executed recent insider sales disclosed in the Form 144?

Recent sales in the past three months were reported by Mikael Cho and Stephanie Lauren Liveranii on several dates including 09/15/2025 and 09/12/2025.

How many shares outstanding does the filing report for GETY?

The filing reports 414,811,306 shares outstanding.